MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2020

    Deep Brain Stimulation impact on Social and Occupational Function in Parkinson’s Disease with Early Motor Complications

    V. Stoker, P. Krack, L. Tonder, A. Schnitzler, J.L Houeto, J. Rau, C. Schade-Brittinger, M. Vidailhet, G. Deuschl (Minneapolis, MN, USA)

    Objective: To investigate the effect of DBS compared with BMT on social, psychosocial and occupational functioning in PD patients ≤ 60 years of age with…
  • MDS Virtual Congress 2020

    Effect of Lactobacillus casei supplementation on clinical response, gut microbiota and faecal metabolites in patients with Parkinson’s disease: A randomized, double-blind, placebo-controlled trial

    X.D Yang, X.Q He, S.Q Xu, VV. Qian, Y. Zhang, YY. Song, Q. Xiao (Shanghai, China)

    Objective: To evaluate the effect of Lactobacillus casei strain Shirota (LcS) supplementation on symptoms, gut microbiota and faecal metabolites in patients with Parkinson's disease (PD).…
  • MDS Virtual Congress 2020

    A Parkinson’s disease dog providing therapeutic intervention in Parkinson’s disease

    C. Buckley, B. O'Callaghan, J. Dowler, N. Austin, E. Reynolds, M. Lowery, T. Lynch (Dublin 7, Ireland)

    Objective: To report a case of Parkinson’s disease gait impairment which responded favourably to intervention with an assistance dog. Background: Gait abnormalities including freezing of…
  • MDS Virtual Congress 2020

    Efficacy and security starting safinamide treatment with 100 mg/day in Parkinson’s disease

    N. Foncea (Galdakao, Spain)

    Objective: Evaluating the efficacy and security starting safinamide treatment with 100 mg/day in PD Background: Safinamide has a unique dopaminergic and non-dopaminergic mode of action…
  • MDS Virtual Congress 2020

    Effectiveness of Carbidopa/Levodopa Enteral Suspension (CLES) in Advanced Parkinson’s Disease (APD) Patients with Moderate to Severe Fatigue: Sub-group Analysis from PROviDE study

    S. Isaacson, J. Aldred, D. Cella, P. Kandukuri, N. Gupta, Y. Jalundhwala, P. Kukreja, I. Pan, R. Pahwa (North Chicago, IL, USA)

    Objective: To examine the effect of CLES at 12 months of follow-up in APD patients with moderate to severe fatigue. Background: Fatigue, one of the…
  • MDS Virtual Congress 2020

    Quantitative study of T-type Ca2+ channels in the subthalamic nucleus neurons towards Parkinson’s disease

    C. Mahapatra (Mumbai, India)

    Objective: From the pathophysiological perspectives, Parkinson’s disease (PD) can be viewed as a prototypical disorder of “brain arrhythmias”. Therefore, the modulation of relevant ion channels…
  • MDS Virtual Congress 2020

    Noninvasive brain stimulation to treat hypokinetic dysarthria in PD: A sham stimulation-controlled trial

    I. Rektorova, L. Brabenec, P. Klobusiakova, M. Kostalova (Brno, Czech Republic)

    Objective: To treat hypokinetic dysarthria (HD) in PD patients using multiple sessions repetitive transcranial magnetic stimulation (rTMS) Background: Based on results from our rTMS exploratory…
  • MDS Virtual Congress 2020

    Efficacy and safety of levodopa-carbidopa intestinal gel (LCIG) for advanced Parkinson’s disease: a Turkish single-centre experience

    Y. Sucullu Karadag (Ankara, Turkey)

    Objective: This study is aimed to investigate the efficacy and adverse effect profile of LCIG among advanced PD patients from a Turkish movement disorder center.…
  • MDS Virtual Congress 2020

    Laryngeal movement disorders as a potential clinical biomarker in multiple system atrophy: Results from the LaPD study

    F. Gandor, A. Vogel, I. Claus, S. Ahring, D. Gruber, H.J Heinze, R. Dziewas, G. Ebersbach, T. Warnecke (Beelitz-Heilstätten, Germany)

    Objective: To systematically assess frequency and nature of laryngeal dysfunction in multiples system atrophy (MSA) compared to Parkinson’s disease (PD) and to identify a potential…
  • MDS Virtual Congress 2020

    GCI-induced neurodegeneration and synucleinopathy in non-human primates

    M. Teil, S. Dovero, M.L Artocarena, M. Bourdenx, G. Porras, B. Mollenhauer, M.T Herrero, M. Vila, J. Obeso, B. Dehay, E. Bezard (Bordeaux, France)

    Objective: This study aimed at determining the potential to induce MSA pathology in non-human primates. Background: Aggregation of alpha-synuclein has been implicated in several neurodegenerative…
  • « Previous Page
  • 1
  • …
  • 42
  • 43
  • 44
  • 45
  • 46
  • …
  • 149
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Welcome to the MDS Abstracts Site
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley